About this trial
This is a single-center randomized controlled trial evaluating the efficacy and safety of short (3 days) versus long (10 days) courses of intermittent hypoxic-hyperoxic training (IHHT) in patients with type 2 diabetes mellitus aged 50-74 years. Participants will be randomized into three groups: 3-day IHHT course (n≥100), 10-day IHHT course (n≥100), or control group receiving gas mixture with constant O2 21% for 10 days (n≥50). The primary outcomes are fasting glucose levels and HbA1c. Secondary outcomes include cardiovascular parameters, quality of life, cognitive function, and biological age.
Eligibility criteria
Qualifiers
Age 50-74 years inclusive
Type 2 diabetes mellitus confirmed by medical documentation
Stable therapy for diabetes and other chronic diseases for at least 4 weeks prior to enrollment
Ability to comply with study protocol requirements
Disqualifiers
Type 1 diabetes mellitus
Acute diabetes complications within 6 months (diabetic ketoacidosis, hyperosmolar hyperglycemic state, lactic acidosis, hypoglycemic coma)
Acute or active chronic infections
Angina pectoris functional class III-IV
Trial design
Treatments tested in this trial
- Intermittent Hypoxic-Hyperoxic Training (3 days)
- Intermittent Hypoxic-Hyperoxic Training (10 days)
- Normoxic gas breathing